Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company that counts Novo Nordisk Foundation as one of its biggest investors, raised $301.5 million in an upsized US initial public ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the most profitable biotech stocks to buy now. On April 13, ...

Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory ...

Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, ...

Massachusetts’ biotech sector has been shedding jobs at a painful clip — but while some companies are cutting deep, one has spent more than $20 billion acquiring five of the state’s most promising ...

In the competitive pharmaceutical and biotechnology industries, where robust patent portfolios are essential for protecting innovative biologics and enabling successful biosimilar development and ...

A leading Mass. biotech company opened a much anticipated lab and processing space. Here's what it looks like.

Nuevocor, a biotechnology company that develops therapies for cardiomyopathies, has appointed Monica Shah, MD, as chief medical officer.  Dr. Shah is a heart failure and transplant cardiologist with ...

L KRAS-Mutant MSS mCRC Demonstrates ~3-4x Improvement in Duration of Response vs. Historical 4-6 Month Benchmark ...